Ali, R., Altalib, N. (2024). Risk Factors of Ischemic stroke in COVID-19 patients. , 23(3), 331-337. doi: 10.52573/ipmj.2024.138326
Rana Ismael Ali; Nameer mohammed Altalib. "Risk Factors of Ischemic stroke in COVID-19 patients". , 23, 3, 2024, 331-337. doi: 10.52573/ipmj.2024.138326
Ali, R., Altalib, N. (2024). 'Risk Factors of Ischemic stroke in COVID-19 patients', , 23(3), pp. 331-337. doi: 10.52573/ipmj.2024.138326
Ali, R., Altalib, N. Risk Factors of Ischemic stroke in COVID-19 patients. , 2024; 23(3): 331-337. doi: 10.52573/ipmj.2024.138326

Risk Factors of Ischemic stroke in COVID-19 patients

Iraqi Postgraduate Medical Journal
Volume 23, Issue 3, July 2024, Pages 331-337    PDF (302.95 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2024.138326
Authors
Rana Ismael Ali* 1; Nameer mohammed Altalib2
1Al Yarmook teaching hospital - Baghdad/ Iraq
2Al Yarmook teaching hospital
Abstract
Background: The Coronavirus Disease 2019 (COVID-19), an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), has become one of the worst pandemics in this century. COVID-19 may increase the risk of acute ischemic stroke similar to the increased risk of 3.2-fold to 7.8-fold seen within the first 3 days after other respiratory tract infections.

Aim: To have the ability of predicting risk of stroke development in COVID

19 patients by relaying on variable parameters involving clinical and inflammatory markers.

Methods and materials: A case control study conducted in Baghdad, the capital of Iraq at Baghdad teaching Hospital, in a period from March 2021 till August 2021.the study included 90 patients tested positive for COVID-19 infection.

Results: The mean age of participants was 58.2 ± 15.6 years (range 22 – 88 years old). The mean age across group A was 65.4 years which was significantly higher than group B age (p=0.0001). Regarding gender, males were representing 53% and 46% of group A and B respectively. Regarding the severity, no mild cases was observed among group A patients (p=0.001). Regarding risk factors, hypertension, DM, history of CVD, smoking, and were associated significantly with developing ischemic stroke (p<0.05). Also, developing respiratory failure was associated with development of ischemic stroke (p=0.002). Regarding inflammatory markers, D-Dimer and ferritin levels were significantly higher among group A patients in comparison to group B patients (p<0.05). While, LDH did not demonstrated significant difference between both groups (p=0.14).

Conclusion: Age, hypertention, D.M, somking, Hx of CVD, Severity of COVID-19 infection, respiratory failure and D-Dimer, ferritin levels were significantly higher among COVID patients who developed stroke. LDH did not demonstrated significant difference.
Keywords
COVID-19,,; ,،,؛Stroke,,; ,،,؛D-Dimer,,; ,،,؛respiratory failure
References
  1. Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Coronavirus COVID-19 global cases by Johns Hopkins CSSE. [cited 2021/11/1]; Available from: https://coronavirus.jhu.edu/map.html.
  2. Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS, Kahan J. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA neurology. 2020;77:1366-72.
  3. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination.N Engl J Med. 2004;351:2611–18.
  4. Warren-Gash C, Blackburn R, Whitaker H, McMenamin J,  Hayward AC.  Laboratory-confirmed  respiratory  infections  as  triggers  for  acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland.Eur Respir J. 2018;51:1701794.
  5. Qureshi AI, Abd-Allah F, Al-Senani F, Aytac E, Borhani-Haghighi A, Ciccone A, Gomez CR, Gurkas E, Hsu CY, Jani V, et al.. Management of acute ischemic stroke in patients with COVID-19 infection: report of an international panel.Int J Stroke. 2020;15:540–54.
  6. Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, Wang D, Mao L, Jin H, HuB. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.Stroke Vasc Neurol. 2020;5:279–84.
  7. Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, Yu H, Tian DS, Wang W. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China.Stroke. 2020;51:2219–23.
  8. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al.. Neurologic Manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China.JAMA Neurol. 2020;77:683–90.
  9. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen  J,  Stals  MAM,  Huisman  MV,  et al.. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis.Thromb Res. 2020; 191:148–50.
  10. Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, Alberici A, Baldelli E, Benini M, Bonacina S, et al.. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.Neurology. 2020;95:e910–e920.
  11. Fara MG, Stein LK, Skliut M, Morgello S, Fifi  JT,  Dhamoon MS. Macrothrombosis and stroke in patients with mild Covid-19 infection.J Thromb Haemost. 2020;18:2031–33.
  12. Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic Circulation. 2007;115:2119-27.
  13. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology. 2020;77:683-90.
  14. Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020 ;51:2002-11.
  15. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, Shah S. Characteristics of ischaemic stroke associated with COVID-19. Journal of Neurology, Neurosurgery & Psychiatry. 2020;91:889-91.
  16. Shahjouei S, Naderi S, Li J, Khan A, Chaudhary D, Farahmand G, Male S, Griessenauer C, Sabra M, Mondello S, Cernigliaro A. Risk of stroke in hospitalized SARS-CoV-2 infected   patients:   a   multinational study. EBioMedicine. 2020; 59:102939.
  17. Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, Yu H, Tian DS, Wang W. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke. 2020;51:2219-23.
  18. Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, Alberici A, Baldelli E, Benini M, Bonacina S, Brambilla L. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020;95:e910-20.
  19. Morassi M, Bagatto D, Cobelli M, D’Agostini S, Gigli GL, Bnà C, Vogrig A. Stroke in patients with SARS-CoV-2 infection: case series. Journal of neurology. 2020;267: 2185-92.
  20. Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS, Kahan J. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAM neurology. 2020;77:1366-72.
  21. Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, Schabaz F, Gillor D, Postel N, Mueller MC, Müller M. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection. 2020:1.
  22. Hassett C, Gedansky A, Mays M, Uchino K. Acute ischemic stroke and COVID-19. Cleve Clin J Med. 2020;87:19-21.
  23. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐ Journal of thrombosis and haemostasis. 2020 ;18:1324-29.
  24. Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, Hu B. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. Journal of intensive care. 2020;8:1-1.
  25. Sakka M, Connors JM, Hékimian G, Martin-Toutain I, Crichi B, Colmegna I, Bonnefont-Rousselot D, Farge D, Frere C. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. JMV-Journal de Médecine Vasculaire. 2020;45:268-74.
  26. Soni M, Gopalakrishnan R, Vaishya R, Prabu P. D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14:2245-49.
  27. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐ Journal of thrombosis and haemostasis. 2020 ;18:1324-29.
  28. Frazer JS, Everden AJ. Emerging patterns of hypercoagulability associated with critical COVID-19: A review. Trends in Anaesthesia and Critical Care. 2020.
  29. Karvigh SA, Vahabizad F, Banihashemi G, Sahraian MA, Gheini MR, Eslami M, Marhamati H, Mirhadi MS. Ischemic stroke in patients with COVID-19 disease: A report of 10 cases from Iran. Cerebrovascular Diseases. 2021;50:239-44.
 

 

Statistics
Article View: 363
PDF Download: 104


Journal Management System. Powered by iJournalPro.com